AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade
F Donelson Smith1, Lorene K Langeberg, Cristina Cellurale
1Howard Hughes Medical Institute, Department of Pharmacology, University of Washington School of Medicine, 1959 Pacific Avenue NE, Seattle, WA 98195, USA.
Abstract:
Mitogen-activated protein kinase (MAPK) cascades propagate a variety of cellular activities. Processive relay of signals through RAF-MEK-ERK modulates cell growth and proliferation. Signalling through this ERK cascade is frequently amplified in cancers, and drugs such as sorafenib (which is prescribed to treat renal and hepatic carcinomas) and PLX4720 (which targets melanomas) inhibit RAF kinases. Natural factors that influence ERK1/2 signalling include the second messenger cyclic AMP. However, the mechanisms underlying this cascade have been difficult to elucidate. We demonstrate that the A-kinase-anchoring protein AKAP-Lbc and the scaffolding protein kinase suppressor of Ras (KSR-1) form the core of a signalling network that efficiently relay signals from RAF, through MEK, and on to ERK1/2. AKAP-Lbc functions as an enhancer of ERK signalling by securing RAF in the vicinity of MEK1 and synchronizing protein kinase A (PKA)-mediated phosphorylation of Ser 838 on KSR-1. This offers mechanistic insight into cAMP-responsive control of ERK signalling events.
Insights
Researchers found that AKAP-Lbc and KSR-1 form a signaling network that enhances mitogen-activated protein kinase (MAPK) pathway activity. This discovery provides new insights into cyclic AMP-responsive control of cell growth and proliferation.
Area of Science:
- Cellular Biology
- Molecular Signaling
- Cancer Research
Background:
- Mitogen-activated protein kinase (MAPK) cascades, particularly the RAF-MEK-ERK pathway, regulate crucial cellular activities like growth and proliferation.
- Dysregulation of ERK signaling is common in various cancers, leading to the development of targeted therapies like sorafenib and PLX4720.
- The influence of natural factors, such as cyclic AMP (cAMP), on ERK1/2 signaling remains incompletely understood.
Purpose of the Study:
- To elucidate the mechanisms underlying ERK1/2 signaling regulation.
- To identify key molecular players involved in signal propagation within the MAPK cascade.
- To understand the role of natural factors like cAMP in modulating ERK signaling.
Main Methods:
- Investigated the roles of A-kinase-anchoring protein (AKAP)-Lbc and kinase suppressor of Ras (KSR)-1 in signal relay.
- Utilized biochemical and cellular assays to analyze protein interactions and signaling complex formation.
- Examined the impact of AKAP-Lbc on RAF, MEK, and ERK1/2 phosphorylation and activity.
Main Results:
- Demonstrated that AKAP-Lbc and KSR-1 form a core signaling network for efficient RAF-MEK-ERK signal propagation.
- Showed that AKAP-Lbc enhances ERK signaling by localizing RAF near MEK1.
- Identified synchronization of protein kinase A (PKA)-mediated phosphorylation of KSR-1 at Ser 838 as a key mechanism.
Conclusions:
- AKAP-Lbc and KSR-1 are critical components of an ERK signaling module.
- AKAP-Lbc acts as an enhancer of ERK signaling through spatial organization and PKA-dependent phosphorylation.
- These findings provide mechanistic insights into cAMP-mediated control of ERK signaling events, relevant to cell growth and cancer.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
cAMP-dependent Protein Kinase Pathways
Intracellular Signaling Cascades
MAPK Signaling Cascades
GPCRs Regulate Adenylyl Cylase Activity
Two...
Amplifying Signals via Second Messengers


